Affiliate disclosure: Some links in this article are affiliate links. We may earn a commission at no additional cost to you.

Medical disclaimer: This article is for informational purposes only. It is not medical advice, diagnosis, or treatment. Consult a qualified healthcare professional before changing your diet, exercise, or supplement regimen.

Miso and natto have been daily foods in Japan for centuries, but they attracted researchers’ attention partly because of a demographic puzzle: postmenopausal Japanese women historically showed lower hip fracture rates than populations with comparable aging demographics and, by international nutritional guidelines, relatively modest calcium intake.

The most studied candidate explanation is isoflavone exposure. Miso is soybeans fermented with koji (Aspergillus oryzae) and salt. Natto is soybeans fermented with Bacillus subtilis var. natto. Both are fermented soybean products, and soybeans are the primary dietary source of isoflavones — phytoestrogens that bind weakly to estrogen receptors and have been tested in randomized controlled trials for their effects on bone mineral density. The drop in estrogen that defines menopause accelerates bone resorption; the research question is whether dietary phytoestrogens from fermented soy have a measurable effect on that process.

The accumulated trial answer: a modest signal, with meaningful caveats.

What is inside the fermented forms

From a composition standpoint, the fermentation process does something specific to soybean isoflavones. Soybeans store isoflavones primarily as glucosides — molecules bound to sugar groups — which require gut enzymatic cleavage before absorption. Fermentation converts a meaningful proportion of these glucosides into aglycone forms: free isoflavones that are absorbed more readily. Naturally fermented miso shows higher aglycone concentrations than unfermented soy products like tofu or edamame. Natto, with its distinct bacterial fermentation, also contains aglycone-enriched fractions alongside a different compound profile.

Natto carries a second bone-relevant compound that miso does not provide in meaningful quantities: vitamin K2 in MK-7 form. Natto is one of the highest dietary sources of MK-7 found in any common food — roughly 850–1,000 µg per 100g, depending on preparation. The bone-related mechanism is distinct from isoflavones: MK-7 activates osteocalcin, a protein produced by bone-building cells that requires carboxylation by vitamin K2 to function properly. Under-carboxylated osteocalcin is correlated with lower bone quality in observational studies.

What the RCT evidence shows

The largest synthesis of the isoflavone-bone density trial record pooled 19 randomized controlled trials of soy isoflavone supplementation in postmenopausal women. The pooled result: isoflavone supplementation was associated with modest but statistically significant improvements in lumbar spine bone mineral density compared to placebo. The effect size was consistently smaller than hormone replacement therapy. The most reliable signal appeared in trials using 40–80 mg isoflavones per day over 6–12 months.

A separate analysis that focused specifically on purified isoflavone extracts, rather than whole soy protein, found similar directional results for lumbar spine bone mineral density. Effects on hip bone mineral density were weaker and less consistent across trials.

What this body of evidence does not establish: it does not show that isoflavone intake reduces fracture incidence. Bone mineral density is a surrogate marker. The trials are not long enough or large enough to detect fracture rate differences, which would require thousands of participants followed over years.

For vitamin K2, the most cited controlled trial is Knapen et al. 2013, published in Osteoporosis International: 180 µg/day of MK-7 supplementation over three years was associated with significantly slower lumbar spine and femoral neck bone mineral density decline in healthy postmenopausal women compared to placebo. Separately, an analysis from the Rotterdam Study cohort found that dietary K2 intake was correlated with reduced vertebral fracture incidence in older adults — an observational finding with the usual confounding limitations, but directionally consistent with the trial data.

Why fermented form may matter more than raw soy

Not everyone absorbs isoflavones equally, and this asymmetry is where fermented soy becomes specifically relevant.

Daidzein, one of the primary soy isoflavones, can be converted by specific gut bacteria into equol — a metabolite with substantially stronger estrogen-receptor binding activity than daidzein itself. Studies consistently find that roughly 50–60% of Japanese adults are equol producers, compared to 25–30% in US populations. This difference is attributed primarily to gut microbiome composition, which is shaped by long-term dietary patterns including lifetime fermented food consumption.

Research on equol producers versus non-producers suggests that producers show larger bone mineral density responses to isoflavone interventions. The equol pathway remains an active research area — it is not yet a validated therapeutic target — but it is a coherent mechanistic reason researchers have begun to separate fermented and non-fermented soy sources in newer study designs. Regular fermented soy consumption may support the gut environment associated with equol production; the evidence for this specific pathway is preliminary but mechanistically plausible.

The practical implication: if you are using miso or natto as isoflavone sources, you are likely working with a more bioavailable form than a soy protein isolate, and the microbial environment that comes with long-term fermented food consumption may contribute to the metabolic conversion that amplifies the phytoestrogen effect.

How miso fits into the isoflavone picture

Naturally fermented miso contains roughly 25–40 mg of isoflavones per 100g, depending on fermentation length and soybean-to-grain ratio. A standard daily serving — approximately 10g of paste in a bowl of miso soup — delivers roughly 2.5–4 mg of isoflavones.

The RCT doses that produced the bone density signal ranged from 40–80 mg isoflavones per day. A single daily bowl of miso soup does not reach that threshold on its own. This does not make miso irrelevant as a dietary source; it means that miso works best as part of a soy-pattern diet that combines multiple sources — tofu, natto, edamame, and miso — rather than as the sole isoflavone vehicle. The traditional Japanese diet provides that pattern as a matter of course, which is probably the more informative model than any single food.

On the label, the relevant form is naturally fermented, refrigerated miso paste with a short ingredient list (soybeans, rice or barley, koji, salt). Shelf-stable, preserved miso represents a different product from what the Japanese cohort studies followed. The miso sourcing guide covers the specifics of what to look for and which brands ship the naturally fermented version internationally.

Practical sourcing

Natto for K2: Frozen natto is available at Japanese grocery stores in the US; Miyasaka and Okame are commonly stocked brands. A single pack (40–50g) delivers roughly 400–500 µg of MK-7 — well above the 180 µg per day used in the Knapen trial, though natto is typically eaten a few times a week rather than in clinical daily-dosing fashion. The flavor is strong — fermented, sticky, with a pronounced ammonia edge — and is an acquired preference for most non-Japanese adults.

For those who want MK-7 without the natto experience, iHerb stocks MK-7 supplements at the relevant dose range — Life Extension, NOW Foods, and Jarrow are stocked there. Look for MK-7 specifically (not MK-4, which is a distinct form with a different dosing evidence base for bone outcomes) and at least 100–180 µg per serving.

Miso for isoflavones: iHerb carries Hikari organic miso (their non-additive line is refrigerated and naturally fermented); Asian specialty retailers carry the wider range including Marukome muten and Cold Mountain in the US. See the miso sourcing guide for specifics.

Isoflavone supplements: For women targeting the 40–80 mg/day RCT range without restructuring their entire diet, iHerb stocks several soy isoflavone supplements — Life Extension Super Absorbable Soy Isoflavones and NOW Foods Soy Isoflavones are both stocked there. Aglycone-standardized forms may offer better absorption; check the label for both form and dose. This is a supplement category worth discussing with a healthcare provider before starting, particularly given the interactions below.

Who should consult their doctor first

The estrogen-receptor activity of isoflavones and the K2 content of natto both create specific situations where medical consultation is appropriate before supplementing or significantly increasing intake:

• History of hormone-sensitive cancers (estrogen-receptor-positive breast cancer, uterine cancer) — isoflavone receptor binding is a pharmacologically relevant consideration in these cases
• Anticoagulant therapy (warfarin) — natto specifically carries a well-documented K2/warfarin interaction: the high MK-7 content counteracts warfarin’s mechanism. The Knapen trial explicitly excluded patients on anticoagulants. This is not a minor concern.
• Thyroid medication (levothyroxine) — soy in significant amounts can interfere with levothyroxine absorption; timing relative to medication matters
• Tamoxifen or other SERMs — isoflavones interact at the estrogen receptor with selective estrogen receptor modulators

Dietary miso consumption at standard serving sizes (one small bowl per day) is unlikely to produce clinically significant versions of these interactions. Supplemental isoflavones at 40–80 mg/day is a different conversation and warrants medical review for the groups above.

A practical one-month starting point

If you want to move from reading to doing, a reasonable entry point is this:

Add natto two to three times a week, starting with one pack eaten with rice, a splash of naturally brewed soy sauce, and Japanese mustard — the standard Japanese preparation that helps offset the texture and sharpens the flavor. Track whether you are building a rhythm with it over a few weeks.

Alongside that, daily miso soup from naturally fermented paste is the dietary isoflavone contribution. It does not hit the RCT threshold alone, but it is part of a cumulative soy pattern, and it is a habit that travels well across years.

If you are postmenopausal and have existing concerns about bone density, the supplement discussion — MK-7 at 100–180 µg/day and possibly a standardized isoflavone product — is worth bringing to your physician, along with bone density screening if you have not had it recently.

The population-level correlation between Japanese fermented soy consumption and favorable bone outcomes is consistent in direction with the RCT evidence. The evidence for a meaningful effect is credible enough to take seriously as a dietary priority. It is not strong enough to stand in for osteoporosis screening or clinical management where indicated — those are parallel tracks, not alternatives.

---

Part of our Japanese diet science series. See also: Koji and fermentation: the Japanese microbiome edge, Nattokinase and blood pressure: what the RCTs show, Real miso paste abroad: sourcing guide.